Surplus Solutions (“Surplus”) is expanding internationally with the acquisition of FAMECO Group (“FAMECO”).
FAMECO is an international market leader in the sale and refurbishment of second-hand analytical laboratory and medical equipment.
FAMECO was formed in 2000 and today services customers in more than 50 countries across Europe, Asia and parts of Africa. The business is ISO 9001-certified and stocks more than 3,000 systems and related spare parts for complex clinical and medical equipment spanning an array of use cases.
Surplus is a leading provider of Equipment Lifecycle Management services focused on procuring and reselling clinical laboratory and processing equipment in the biotechnological, pharmaceutical and nutraceutical markets. Through the acquisition of FAMECO, Surplus expects to gain an even stronger foothold in international markets and to be able to roll out refurbishment and technical services in the USA.
Surplus is a portfolio company of NMS Capital (“NMS”), a New York-based private equity firm focused on acquiring medium-sized growth companies, particularly in the healthcare sector. NMS was formed in 2010 and manages more than USD 1.5 billion.
Accura advised Surplus Solutions and NMS Capital in connection with the transaction in collaboration with McDermott Will & Emery.